ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ Π½Π΅ΠΏΠΎΠ»ΠΈΠΏΠΎΠ·Π½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° ΡΠΎΠ»ΡΡΠΎΠΉ ΠΊΠΈΡΠΊΠΈ
Π‘Π΅ΠΌΠ΅ΠΉΠ½ΡΠΉ Π°Π½Π°ΠΌΠ½Π΅Π·" (Π½Π°Π»ΠΈΡΠΈΠ΅ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ Ρ ΠΊΡΠΎΠ²Π½ΡΡ ΡΠΎΠ΄ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠΎΠ² I ΠΈ II ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΡΠΎΠ΄ΡΡΠ²Π°), ΠΊΠΎΡΠΎΡΡΠΉ ΡΠ°ΠΊΠΆΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ Π²Π°ΠΆΠ½ΡΠΌ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ-Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠΌ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠΎΡΠΌΡ ΡΠ°ΠΊΠ°, Π·Π°ΡΠ°ΡΡΡΡ Π½Π΅ ΠΏΡΠΎΡΠ»Π΅ΠΆΠΈΠ²Π°Π΅ΡΡΡ, Π²ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ ΠΏΡΠ΅ΠΆΠ΄Π΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π³ΠΈΠ±Π΅Π»ΠΈ ΡΠΎΠ΄ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠΎΠ² ΠΈΠ»ΠΈ ΠΎΡΡΡΡΡΡΠ²ΠΈΡ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ. ΠΠΎ-Π²ΠΈΠ΄ΠΈΠΌΠΎΠΌΡ, Π² ΠΏΠΎΠ΄ΠΎΠ±Π½ΡΡ ΡΠΈΡΡΠ°ΡΠΈΡΡ ΡΠ»Π΅Π΄ΡΠ΅Ρ ΡΠ΄Π΅Π»ΡΡΡ Π±ΠΎΠ»ΡΡΠ΅Π΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ Π΄ΡΡΠ³ΠΈΠΌ ΠΊΡΠΈΡΠ΅ΡΠΈΡΠΌ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ΅Π»Π΅Π² Π.Π€. Π ΠΎΠ»Ρ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π² ΡΡΠΈΠΎΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ ΡΠ°ΠΊΠ° ΡΠΎΠ»ΡΡΠΎΠΉ ΠΊΠΈΡΠΊΠΈ. // ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ III ΡΡΠ΅Π·Π΄Π° ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΎΠ² ΠΈ ΡΠ°Π΄ΠΈΠΎΠ»ΠΎΠ³ΠΎΠ² 2004. — Π§Π°ΡΡΡ 2. — Π‘. 64 — 67.
- ΠΠ°ΡΡΠΊΠ°Π²ΡΠ΅Π²Π° Π .Π€., ΠΠ°Π·ΡΠ±ΡΠΊΠ°Ρ Π’. Π., ΠΠΌΠΎΡΠ΅Π½ΠΊΠΎ Π€. Π., ΠΡΠ±ΡΠ΅Π½ΠΊΠΎ Π. Π. ΠΠ΅Π½ΠΎΠ΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ°, ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ° Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΡ ΡΠΎΡΠΌ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ. // ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ III ΡΡΠ΅Π·Π΄Π° ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΎΠ² ΠΈ ΡΠ°Π΄ΠΈΠΎΠ»ΠΎΠ³ΠΎΠ² 2004. — Π§Π°ΡΡΡ. 2. — Π‘. 58−63.
- ΠΠ΅ΡΠ°Π±ΠΈΡΠ²ΠΈΠ»ΠΈ Π.Π., ΠΠΎΠΏΠΎΠ²Π° Π‘. Π., Π‘ΠΊΡΡΠ±ΠΈΠ½Π° Π. Π. Π Π°ΠΊ ΠΎΠ±ΠΎΠ΄ΠΎΡΠ½ΠΎΠΉ ΠΊΠΈΡΠΊΠΈ: Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ // ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ IX ΠΡΠ΅ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΠΈ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΎΠ². 2002. — Π‘. 418 — 420.
- ΠΠ΅ΡΠ°Π±ΠΈΡΠ²ΠΈΠ»ΠΈ Π.Π. ΠΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ»ΡΠΆΠ±Π° Π‘Π°Π½ΠΊΡ-ΠΠ΅ΡΠ΅ΡΠ±ΡΡΠ³Π° // Π‘ΠΠ±, ΠΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠ°Ρ ΠΏΡΠ΅ΡΡΠ° 2003. — Π‘. 143
- Π‘Π°Π²ΠΈΠ½Π° Π.Π., ΠΠ°ΡΠΈΠ»ΡΠ΅Π² Π‘. Π., Π‘ΠΈΠΌΠΎΠ½ΠΎΠ² Π. Π., ΠΠΎΠΈΡΠ΅Π΅Π½ΠΊΠΎ Π. Π. ΠΡΠ΅Π½ΠΊΠ° Π²Π»ΠΈΡΠ½ΠΈΡ ΡΠΈΡΠΎΡΠ΅Π΄ΡΠΊΡΠΈΠ²Π½ΡΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ Π½Π° Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΌΠ΅ΡΠ°ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ°ΠΊΠΎΠΌ ΠΎΠ±ΠΎΠ΄ΠΎΡΠ½ΠΎΠΉ ΠΊΠΈΡΠΊΠΈ // ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ IX ΠΡΠ΅ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΠΈ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΎΠ². 2002. — Π‘. 428 — 431.
- Π‘ΠΊΡΡΠ±ΠΈΠ½Π° Π.Π., ΠΠ΅ΡΠ°Π±ΠΈΡΠ²ΠΈΠ»ΠΈ Π. Π., ΠΠΎΠΏΠΎΠ²Π° Π‘. Π. ΠΡΠ΅Π½ΠΊΠ° ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ ΡΠ°ΠΊΠΎΠΌ ΠΎΠ±ΠΎΠ΄ΠΎΡΠ½ΠΎΠΉ ΠΊΠΈΡΠΊΠΈ Π² Π‘Π°Π½ΠΊΡ-ΠΠ΅ΡΠ΅ΡΠ±ΡΡΠ³Π΅ // ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ IX ΠΡΠ΅ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΠΈ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΎΠ². 2002. — Π‘. 434 -436.
- Π‘ΡΠ°ΡΠΈΠ½ΡΠΊΠΈΠΉ Π.Π., ΠΠ΅ΡΡΠΎΠ²Π° Π. Π., Π§ΠΈΡΡΠΎΠ² Π. Π., ΠΈ Π΄Ρ. ΠΠ°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π ΠΎΡΡΠΈΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌΠΈ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈ Π² 2000 Π³. // Π ΠΎΡΡΠΈΠΉΡΠΊΠΈΠΉ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΆΡΡΠ½Π°Π» 2002. — № 3. — Π‘. 39−44.
- Π‘ΠΈΠΌΠΎΠ½ΠΎΠ² Π.Π. Π₯ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΠΊΠ° ΠΏΡΡΠΌΠΎΠΉ ΠΊΠΈΡΠΊΠΈ, ΠΏΡΠΈ Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΎΡΠ΄Π°Π»Π΅Π½Π½ΡΡ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΎΠ². Π¦ΠΈΡΠΎΡΠ΅Π΄ΡΠΊΡΠΈΠ²Π½ΡΠ΅, ΠΏΠ°Π»Π»ΠΈΠ°ΡΠΈΠ²Π½ΡΠ΅, ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ. // ΠΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡ: ΠΈΠ·Π±ΡΠ°Π½Π½ΡΠ΅ Π»Π΅ΠΊΡΠΈΠΈ. 2004- - Π‘. 207−214.
- Π§ΠΈΡΡΠΎΠ² Π.Π., Π‘ΡΠ°ΡΠΈΠ½ΡΠΊΠΈΠΉ Π. Π., ΠΠ΅ΡΡΠΎΠ²Π° Π. Π. ΠΠ»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ Π² Π ΠΎΡΡΠΈΠΈ Π² 2002 Π³ΠΎΠ΄Ρ // Π., ΠΠΠΠΠ ΠΈΠΌ. Π. Π. ΠΠ΅ΡΡΠ΅Π½Π°. -2004- - Π‘. 256
- Aarnio Π., Mecklin J.P., Aaltonen L.A. et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. // Int. J. Cancer. -1995.- Vol. 64-P. 430−433.
- Aaltonen L.A., Peltomaki P., Leach F.S. et al. Clues to the pathogenesis of familial colorectal cancer. // Science. 1993. — Vol. 260. — P. 812 — 816.
- Adachi M., Muto Π’., Okinaga K., Morioka Y. Clinicopathologic features of the flat adenoma. // Dis. Colon Rectum. 1991. — Vol. 34. — P. 981 — 986.
- Al-Taie O., Mork H., Seufert J. et al. Hereditary nonpolyposis colorectal carcinoma (HNPCC). Current review of etiology, clinical aspects, diagnosis and therapy // Med. Klin. (Munich). 2001. — Vol. 96. — P. 529 — 538.
- Albano W.A., Lynch H.T., Recabaren J.A. et al. Familial cancer in an oncology clinic. // Cancer. 1981. — Vol. 47. — P. 2113 — 2118.
- Boland C.R., Troncale F.J. Familial colonic cancer without antecedent polyposis. // Ann. Intern. Med. 1984. — Vol. 100. — P. 700 — 701.
- Bourne Π’.Π., Whitehead M.I., Campbell S. et al. Ultrasound screening for familial ovarian cancer. // Gynecol. Oncol. 1991. — Vol. 43 — P. 92 — 97.
- Burke W., Petersen G., Lynch P. et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. // JAMA. 1997. — Vol. 277. -P. 915−919.
- Bhattacharyya N.P., Skandalis A., Ganesh A. et al. Mutator phenotypes in human colorectal carcinoma cell lines. // Proc. Natl. Acad. Sci. USA- 1994. Vol. 91. -P. 6319 -6323.
- Baba S. Hereditary nonpolyposis colorectal cancer: an update. // Dis. Colon Rectum 1997. — Vol. 40 (Suppl). — P. S 86 — 95.
- Boyer J.C., Umar A., Risinger J.I. et al. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. // Cancer Res. 1995. -Vol. 55.-P. 6063−6070.
- Billings P.R., Kohn M.A., de Cuevas M. et al. Discrimination as a consequence of genetic testing. // Am. J. Hum. Genet. 1992. — Vol. 50. — P. 476 — 482.
- Bodmer W., Bishop Π’., Karran P. Genetic steps in colorectal cancer. // Nat. Genet.- 1994.-Vol. 6.-P. 217−219.
- Branch P., Bicknell D.C., Rowan A. et al. Immune surveillance in colorectal carcinoma. // Nat. Genet. 1995. — Vol. 9. — P. 231 — 232.
- Bubb V.J., Curtis L.J., Cunningham C., Dunlop M.G. et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. // Oncogene. -1996. Vol. 12 — P. 2641 — 2649.
- Church J., Kiringoda R., La Guardia L. Inherited Colorectal Cancer Registries in the United States: The state of the Union. // Dis. Colon Rectum 2004. — Vol. 47.- P. 674−678
- Chung D. C, Rustgi A.K. DNA mismatch repair and cancer. // Gastroenterology. -1995. Vol. 109. — P. 1685 — 1699.
- D’Emilia J.C., Rodriguez-Bigas M.A., Petrelli N.J. The Clinical and Genetic Manifestations of Hereditary Nonpolyposis Colorectal Carcinoma // The American J. of Surgery 1995. -Vol. 169.-P. 368−372.
- Dunlop M.G., Farrington S.M., Carothers A.D. et al. Cancer risk associated with germline DNA mismatch repair gene mutations. // Hum. Mol. Genet. 1997. -Vol. 6.-P. 105−110.
- Emery J., Murphy M., Lucassen A. Hereditary cancer the evidence for current recommended management. // The Lancet Oncology. — 2000. — P. 9−16.
- Eddy D.M. Screening for colorectal cancer. // Ann. Intern. Med. 1990. — Vol. 113.-P. 373−384.
- Fujiwara Π’., Stolker J.M., Watanabe T. et al. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. // Am. J. Pathol. 1998. — Vol. 153. — P. 1063 — 1078.
- Frayling I.M. Microsatellite instability. // Gut. 1999. — Vol. 45. — P. 1−4.
- Frei J.V. Hereditary nonpolyposis colorectal cancer (Lynch syndrome II). Diploid malignancies with prolonged survival. // Cancer. 1992. — Vol. 69. — P. 1108 -1111.
- Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. // Cell. -1990.-Vol. 61. -P. 759−767.
- Hawk E, Lubet R, Limburg P. Chemoprevention in hereditary colorectal cancer syndromes. // Cancer. 1999. — Vol. 86 (Suppl). — P. 2551 — 2563.
- Helm J.F., Sandler R.S. Colorectal cancer screening. // Med. Clin. North Am.1999. Vol. 83. — P. 1403 — 1422.
- Jarvinen H.J., Mecklin J.P., Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. // Gastroenterology. -1995. Vol. 108. — P. 1405 — 1411.
- Jarvinen H.J., Aarnio M., Mustonen H. et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. // Gastroenterology. 2000. — Vol. 118. — P. 829 — 834.
- Jass J.R., Stewart SM. Evolution of hereditary non-polyposis colorectal cancer. // Gut. 1992. — Vol. 33. — P. 783 — 786.
- Jass J.R., Smyrck T.C., Stewart S.M. et al. Pathology of hereditary non-polyposis colorectal cancer. //Anticancer Res. 1994. — Vol. 14. — P. 1631 — 1634.
- Jass J.R., Do K.A., Simms L.A. et al. Morphology of sporadic colorectal cancer with DNA replication errors. // Gut. 1998. — Vol. 42. — P. 673 — 679.
- Jass J.R. Diagnosis of hereditary non-polyposis colorectal cancer // Histopathology 1998. Vol. 32. — P. 491 — 497.
- Jass J.R., Biden K.G., Cummings M.C. et al. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. // J. Clin. Pathol. 1999. — Vol. 52. — P. 455 — 460.
- Jass J.R., Young J., Leggett B.A. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. // Histopathology. 2000. — Vol. 37. — P. 295 301.
- Jass J.R. Histopathology of early colorectal cancer. // World J. Surg. 2000. — Vol. 24.-P. 1016- 1021.
- Jass J.R. Pathology of hereditary nonpolyposis colorectal cancer. // Ann. N Y Acad. Sci. 2000. — Vol. 910. — P. 62 — 73.
- Jass J.R. Clinical Significance of Early-Onset «Sporadic» Colorectal Cancer With Microsatellite Instability. // Dis. Colon Rectum, 2003. — Vol. 46. — P. 1305 -1309.
- Jen J., Kim H., Piantadosi S. et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. // N. Engl. J. Med. 1994. — Vol. 331. — P. 213 — 221.
- Johnson R.E., Kowali G.K., Prakash L., Prakash S. Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability. // J. Biol. Chem. 1996. — Vol. 271. — P. 7285 — 7288.
- Kolodner RD, Tytell JD, Schmeits JL, Kane MF, Gupta RD, Weger J et al. Germ-line msh6 mutations in colorectal cancer families. // Cancer Res. 1999. — Vol. 59.- P. 5068 5074.
- Knudson A.G. Hereditary cancer: two hits revisited. // J. Cancer Res. Clin. Oncol.- 1996. Vol. 122. — P. 135 — 140.
- Kerber R.A., Slattery M.L. Comparison of self-reported and database-linked family history of cancer data in a case-control study. // Am. J. Epidemiol. 1997. -Vol. 146. — P. 244 — 248.
- Kodish E., Wiesner G.L., Mehlman M., Murray T. Genetic testing for cancer risk: how to reconcile the conflicts. // JAMA. 1998. — Vol. 279 — P. 179 — 181.
- Kahlenberg M.S., Stoler D.L., Rodriguez-Bigas M.A. et al. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. // Cancer. 2000. — Vol. 88. — P. 1814 — 1819.
- Marra G., Boland C.R. Hereditary Nonpolyposis Colorectal Cancer: the Syndrome, the Genes, and Historical Perspectives. // J. of the Nat. Cancer Inst. 1995. — Vol. 87.-P. 1114−1125.
- Mecklin J.P., Sipponen P., Jarvinen H.J. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. // Dis. Colon Rectum. 1986. — Vol. 29. -P. 849−853.
- Moore J., Cowled P. Hereditary non-polyposis colorectal cancer syndrome. // Aust. N. Z. J. Surg. 1999. — Vol. 69. — P. 6 — 13.
- Mecklin J.P., Jarvinen H.J. Clinical features of colorectal carcinoma in cancer family syndrome. // Dis. Colon Rectum. 1986. — Vol. 29. — P. 160 — 164.
- Myrhoj Π’., Bisgaard M.L., Bernstein I. et al. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. // Scand. J. Gastroenterol. 1997. — Vol. 32. — P. 572 — 576.
- Moslein G., Krause-Paulus R., Hegger R. et al. Clinical aspects of hereditary nonpolyposis colorectal cancer. // Ann. N Y Acad. Sci. 2000. — Vol. 910. — P. 7583.
- Marsischky G.T., Filosi N., Kane M.F., Kolodner R. Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. // Genes. Dev. 1996. — Vol. 10. — P. 407 — 420.
- Messerini L., Mori S., Zampi G. Pathologic features of hereditary non-polyposis colorectal cancer // Tumori. 1996- Vol. 2- - P. 114 — 116
- Nicolaides N.C., Papadopoulos N., Liu B. et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. // Nature. 1994. — Vol. 371. — P. 75−80.
- Nilbert M., Planck M., Fernebro E. et al. Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. // Eur. J. Cancer. 1999. — Vol. 35. -P. 942−945.
- Olschwang S., Hamelin P., Laurent-Puig P. et al. Alternative genetic pathways in colorectal carcinogenesis. // Proc. Natl. Acad. Sci. USA. 1997. — Vol. 94. — P. 122 — 127.
- Olschwang S., Slezak P., Roze M. et al. Somatically acquired genetic alterations in flat colorectal neoplasias. // Int. J. Cancer. 1998. — Vol. 77. — P. 366 — 369.
- Peltomaki P. Deficient DNA mismatch repair: a common etiologic for colon cancer. // Human Mol. Gen. 2001. — Vol. 10. — P. 735 — 740.
- Peltomaki P., Vasen H., Jass J.R. Hereditary nonpolyposis colorectal cancer. // Path, and Gen. 2004. — Vol. 2. — P. 126 — 128.
- Park J.G., Yuan Y. Genetic identification and management of hereditary nonpolyposis colorectal cancer // Int. J. Oncol. 1998. — Vol. 12. — P. 947 — 955.
- Papadopoulos N., Nicolaides N.C., Liu B. et al. Mutations of GTBP in genetically unstable cells. // Science. 1995. — Vol. 268. — P. 1915 — 1917.
- Pare Y.R., Hailing K.C., Wang L. et al: HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. // Cancer Res. 2000. — Vol. 60. -P. 2225 -2231.
- Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R. et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. // J. Natl. Cancer Inst. 1997. — Vol. 89.-P. 1758- 1762.
- Rosen L., Bub D.S., Reed J.F., Nastasee S.A. Hemorrhage following colonoscopic polypectomy. // Dis. Colon Rectum. 1993. — Vol. 36. — P. 1126 — 1131.
- Shashidharan M., Smyrk Π’., Lin, K.M. et al. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population. //β’Dis Colon Rectum. 1999- Vol — 6: — P. 722 — 726.
- Shashidharan M., Smyrk Π’., Lin K. M et al. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population. // Science. 2003. — Vol. 84. — P. 350−353
- Shia J., Ellis N.A., Paty P.B. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer//Am. J. Surg. Pathol. 2003- - Vol. 11- - P. 1407 — 1417.
- Schlesselman J.J. Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner’s guide to meta-analysis. // Hum. Reprod. 1997. -Vol. 12.-P. 1851 — 1863.
- Strand M., Prolla T.A., Liskay R.M., Petes T.D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. // Nature -1993. Vol. 365. — P. 274 — 276.
- Todor V., Chirila D., Tompa S. Familian colorectal cancer: The Lynch syndrome. // Chirurgia (Bucur). 1998. — Vol. 93. — P. 427 — 432.
- Theis Π., Boyd N., Lockwood G., Tritchler D. Accuracy of family cancer history in breast cancer patients. // Eur. J. Cancer Prev. 1994. — Vol. 3. — P. 321 — 327.
- Thorson A.G., Knezetic J.A., Lynch H.T. A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome). // Dis. Colon Rectum 1999. -Vol.42.-P. 1−9.
- Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. // Science. 1993. — Vol. 260. — P. 816−19.
- Vernava A.M., Longo W.E. Complications of endoscopic polypectomy. // Surg. Oncol. Clin. North Am. 1996. — Vol. 5. — P. 663 — 673.
- Vasen H.F., den Hartog Jager F.C., Menko F.H., Nagengast F.M. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. // Am. J. Med. 1989. — Vol. 86. — P. 278 — 281.
- Vasen H.F., Mecklin J.P., Khan P.M., Lynch H.T. The International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer (ICG-HNPCC). // Dis. Colon Rectum 1991. — Vol. 34. — P. 424 — 425.
- Vasen H.F., Nagengast F.M., Khan P.M. Interval cancers in hereditary nonpolyposis colorectal cancer (Lynch syndrome). // Lancet 1995. — Vol. 345. — P. 1183- 1184.
- Vasen H.F., Wijnen J.T., Menko F.H. et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. // Gastroenterology 1996. — Vol. 110 — P. 1020 — 1027.
- Vasen H.F., Watson P., Mecklin J.P., Lynch H.T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. // Gastroenterology. 1999. -Vol. 116.-P. 1453- 1456.
- Verma L., Kane M.F., Brassett C. et al. Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer. // J Med. Genet. 1999. — Vol. 36. — P. 678−682.
- Watson P., Vasen H.F., Mecklin J.P. et al. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. //Am. J. Med. 1994. — Vol. 96. — P. 516−520.
- Warthin A.S. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 18 951 913. //Arch. Intern. Med. 1913. — Vol. 12. — P. 546 — 555.
- Warthin AS. The further study of a cancer family. // J. Cancer Res. 1925. — Vol. 9. — P. 279 — 286.
- Warthin A.S. Hereditaly of carcinoma in man. // Ann. Intern. Med. 1931. — Vol. 4.-P. 681 -696.
- William A., Recabaren J., Lynch H.T. Natural History of Hereditary Cancer of the Breast and Colon. // Cancer. 1982. — Vol. 50. — P. 360 — 363
- Weitzel J.N. The current social, political, and medical role of genetic testing in familial breast and ovarian carcinomas. // Curr. Opin. Obstet. Gynecol. 1999. -Vol. 11.-P. 65 -70.
- Watanabe Π’., Muto Π’., Sawada Π’., Miyaki M. Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma. // Cancer. -1996. Vol. 77. — P. 627 — 634.
- Wright C.M., Dent O.F., Barker M. et al. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage Π‘ colorectal cancer. // Br. J. Surg. 2000. — Vol. 87 — P. 1197 — 1202.
- Winawer S.J., Zauber A.G., Ho M.N. et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. // N. Engl. J. Med. 1993. — Vol. 329. — P. 1977 — 1981.
- Wijnen J., de Leeuw W., Vasen H. et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. // Nat. Genet. 1999. — Vol. 23. — P. 142 144.
- Wright C.L., Stewart I.D. Histopathology and mismatch repair status of 458consecutive colorectal carcinomas.
- Am. J. Surg. Pathol. 2003- - Vol. 11- - P. 1393 — 1406.
- Wullenweber H.P., Sutter C., Autschbach F. et al. Evaluation of Bethesda guidelines in relation to microsatellite instability. // Dis. Colon Rectum. 2001. -Vol.44(9). — P. 1281 — 1289.
- Wullenweber H.P., Sutter C., Autschbach F. et. al. Evaluation of Bethesda guidelines in relation to microsatellite instability. // Dis. Colon Rectum. 2001 -Vol. 44-P. 1281−1289.
- Winawer S. J, Zauber A.G., O’Brien M.J. et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. // N. Engl. J. Med. 1993. — Vol. 328. — P. 901 — 906.
- Webb W.A., McDaniel L., Jones L. Experience with 1000 colonoscopic polypectomies. // Ann. Surg. 1985. — Vol. 201. — P. 626 — 632.
- Wu Y., Berends M.J., Mensink R.G. et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. // Am. J. Hum. Genet. 1999. — Vol. 65. — P. 12 911 298.